GW Pharmaceuticals Plc

Available to platforms

GW Pharmaceuticals Plc (Ticker: GWPH) was a biopharmaceutical company focused on developing cannabinoid-based medicines. Its flagship product, Epidiolex, became the first FDA-approved cannabidiol (CBD) treatment for epilepsy-related conditions, including Lennox-Gastaut syndrome and Dravet syndrome. In 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals, expanding its portfolio to include innovative treatments in neuroscience and oncology.

GW Pharmaceuticals Plc - GWPH stocks live chart

Analyze price movements of GW Pharmaceuticals Plc online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous GWPH quotes, get all necessary information for adding GW Pharmaceuticals Plc to your investment portfolio.

You can invest in GW Pharmaceuticals Plc and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like GW Pharmaceuticals Plc, in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of GWPH does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for GW Pharmaceuticals Plc (GWPH).

You can trade GW Pharmaceuticals Plc (GWPH) on the R StocksTrader platform.

You can trade online GW Pharmaceuticals Plc (GWPH) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts